HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poly(rC) binding protein 2 acts as a negative regulator of IRES-mediated translation of Hr mRNA.

Abstract
During the hair follicle (HF) cycle, HR protein expression is not concordant with the presence of the Hr mRNA transcript, suggesting an elaborate regulation of Hr gene expression. Here we present evidence that the 5' untranslated region (UTR) of the Hr gene has internal ribosome entry site (IRES) activity and this activity is regulated by the binding of poly (rC) binding protein 2 (PCBP2) to Hr mRNA. Overexpression and knockdown of PCBP2 resulted in a decrease in Hr 5' UTR IRES activity and an increase in HR protein expression without changing mRNA levels. We also found that this regulation was disrupted in a mutant Hr 5' UTR that has a mutation responsible for Marie Unna hereditary hypotrichosis (MUHH) in both mice and humans. These findings suggest that Hr mRNA expression is regulated at the post-transcriptional level via IRES-mediated translation control through interaction with PCPB2, but not in MUHH.
AuthorsJeong-Ki Kim, Injung Kim, Keonwoo Choi, Jee-Hyun Choi, Eunmin Kim, Hwa-Young Lee, Jongkeun Park, Sungjoo Kim Yoon
JournalExperimental & molecular medicine (Exp Mol Med) Vol. 50 Issue 2 Pg. e441 (02 09 2018) ISSN: 2092-6413 [Electronic] United States
PMID29422543 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 5' Untranslated Regions
  • Internal Ribosome Entry Sites
  • Pcbp2 protein, mouse
  • RNA, Messenger
  • RNA-Binding Proteins
  • Transcription Factors
  • hr protein, mouse
Topics
  • 5' Untranslated Regions
  • Animals
  • Cell Line
  • Gene Expression Regulation
  • Genes, Reporter
  • Humans
  • Internal Ribosome Entry Sites
  • Mice
  • Mutation
  • Protein Biosynthesis
  • RNA, Messenger (genetics, metabolism)
  • RNA-Binding Proteins (genetics, metabolism)
  • Transcription Factors (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: